See more : Taiwan Liposome Company, Ltd. (TLC) Income Statement Analysis – Financial Results
Complete financial analysis of MustGrow Biologics Corp. (MGROF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MustGrow Biologics Corp., a leading company in the Agricultural Inputs industry within the Basic Materials sector.
You may be interested
- ContextLogic Inc. (LOGC) Income Statement Analysis – Financial Results
- Medicure Inc. (MPH.V) Income Statement Analysis – Financial Results
- CLSA Premium Limited (6877.HK) Income Statement Analysis – Financial Results
- Luk Fook Holdings (International) Limited (LKFLF) Income Statement Analysis – Financial Results
- Target Global Acquisition I Corp. (TGAAW) Income Statement Analysis – Financial Results
MustGrow Biologics Corp. (MGROF)
About MustGrow Biologics Corp.
MustGrow Biologics Corp., an agricultural biotech company, focuses om development and commercialization of natural biopesticide, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops. The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets. In addition, it focuses on providing CannaPM, an active ingredient to treat fungal soil diseases, as well as foliar diseases. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.71M | 6.48K | 12.87K | 0.00 | 0.00 | 2.00K | 2.10K | 109.02K | 12.42K |
| Cost of Revenue | 384.69K | 298.21K | 203.59K | 187.68K | 74.19K | 44.74K | 48.71K | 21.26K | 75.80K |
| Gross Profit | 4.33M | -291.73K | -190.72K | -187.68K | -74.19K | -42.74K | -46.60K | 87.76K | -63.38K |
| Gross Profit Ratio | 91.84% | -4,502.72% | -1,482.03% | 0.00% | 0.00% | -2,136.90% | -2,217.13% | 80.50% | -510.45% |
| Research & Development | 857.07K | 475.86K | 458.38K | 149.25K | 83.00K | 13.54K | 749.00 | 21.26K | 75.80K |
| General & Administrative | 3.12M | 4.52M | 2.00M | 2.96M | 1.35M | 1.84M | 36.45K | 20.44K | 491.92K |
| Selling & Marketing | 558.60K | 696.82K | 567.93K | 263.55K | 36.47K | 9.49K | 0.00 | 0.00 | 0.00 |
| SG&A | 3.68M | 5.22M | 2.57M | 3.22M | 1.39M | 1.84M | 36.45K | 20.44K | 491.92K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.54M | 5.69M | 3.02M | 3.37M | 1.47M | 1.86M | 36.45K | 20.44K | 519.35K |
| Cost & Expenses | 4.92M | 5.69M | 3.02M | 3.37M | 1.47M | 1.86M | 36.45K | 20.44K | 595.15K |
| Interest Income | 211.60K | 103.55K | 3.32K | 45.87K | 45.88K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 10.07K | 52.77K | 45.87K | 45.88K | 40.24K | 27.31K | 0.00 | 0.00 |
| Depreciation & Amortization | -466.01K | 5.25M | 2.73M | 3.20M | 1.35M | 892.64K | 1.08K | 1.08K | 2.31K |
| EBITDA | -676.94K | 0.00 | 0.00 | 0.00 | 0.00 | -1.85M | -170.25K | -147.89K | -555.31K |
| EBITDA Ratio | -14.37% | -86,148.73% | -23,398.17% | 0.00% | 0.00% | -92,656.85% | -1,734.11% | -18.75% | -4,472.14% |
| Operating Income | -210.93K | -5.58M | -3.01M | -3.37M | -1.47M | -1.85M | -36.45K | -20.44K | -557.62K |
| Operating Income Ratio | -4.48% | -86,148.73% | -23,398.17% | 0.00% | 0.00% | -92,656.85% | -1,734.11% | -18.75% | -4,490.77% |
| Total Other Income/Expenses | -466.01K | -313.51K | -334.69K | -109.90K | -164.09K | -40.24K | 250.74K | 108.35K | -25.12K |
| Income Before Tax | -676.94K | -5.57M | -3.06M | -3.31M | -1.52M | -1.89M | -36.45K | -20.44K | -582.73K |
| Income Before Tax Ratio | -14.37% | -85,905.87% | -23,808.18% | 0.00% | 0.00% | -94,668.85% | -1,734.11% | -18.75% | -4,693.03% |
| Income Tax Expense | 0.00 | -5.24M | -2.73M | -3.15M | -1.35M | -161.14K | 88.55K | -24.40K | 0.00 |
| Net Income | -676.94K | -5.57M | -3.06M | -3.31M | -1.52M | -1.89M | -36.45K | -20.44K | -582.73K |
| Net Income Ratio | -14.37% | -85,905.87% | -23,808.18% | 0.00% | 0.00% | -94,668.85% | -1,734.11% | -18.75% | -4,693.03% |
| EPS | -0.01 | -0.11 | -0.07 | -0.09 | -0.06 | -0.08 | 0.00 | 0.00 | -0.03 |
| EPS Diluted | -0.01 | -0.11 | -0.07 | -0.09 | -0.06 | -0.08 | 0.00 | 0.00 | -0.03 |
| Weighted Avg Shares Out | 49.90M | 49.01M | 43.74M | 37.31M | 25.29M | 24.99M | 24.99M | 24.99M | 20.91M |
| Weighted Avg Shares Out (Dil) | 49.89M | 49.01M | 43.74M | 37.31M | 25.29M | 24.99M | 24.99M | 24.99M | 20.91M |
MustGrow Biologics joins consortium fighting fungal threat to banana industry
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has joined an international consortium that is looking for ways to combat the fungal disease currently threatening the banana industry. The company has been accepted as a member of the Global Alliance Against TR4, which brings together food...
MustGrow Joins Industry Consortium "Global Alliance Against TR4" to defeat Banana Fungal Disease Fusarium wilt TR4
MustGrow joins alliance of international banana leaders, including Bayer, Chiquita, Del Monte, Dole, and Fyffes. MustGrow is collaborating to bring its uniquely effective technologies to help address this global issue.
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
Saskatoon, Saskatchewan--(Newsfile Corp. - June 27, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the results of its 2024 annual meeting of shareholders (the "Meeting") held on June 27,...
MustGrow secures California registration and organic certification for biofertility product TerraSante
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has received the California Department of Food Agriculture registration approval for its mustard-based biofertility product TerraSante. This means MustGrow is now authorized to begin sales of TerraSante in California, which has a...
MustGrow Receives California Registration and Organic Approval for TerraSante(TM) Biofertility Product
MustGrow has received the California Department of Food Agriculture approval to commence sales of TerraSante TM , an organic biofertility product, in California. Additionally, MustGrow has received organic certification from California's Organic Input Material (OIM) Program.
MustGrow inks exclusive distribution agreement for biofertility product TerraSante
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has signed an exclusive distribution agreement with fertilizer retailer G.S. Long Co for its biofertility product TerraSante in Oregon and Washington State.
MustGrow Signs Exclusive Distribution Agreement with G.S. Long Co., Inc. for TerraSante(TM) Biofertility Product
G.S. Long Co., Inc. has exclusive distribution rights for MustGrow's TerraSante TM biofertility product in Oregon and Washington State. MustGrow's mustard-derived TerraSante TM is organic certified through the USDA National Organic Program (OMRI Listed®).
MustGrow Biologics to Present at the Planet MicroCap Showcase
MustGrow Biologics to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 Saskatoon, Saskatchewan--(Newsfile Corp. - April 17, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE:...
MustGrow Oregon sales approval another positive step toward revenue growth
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) gaining approval to sell its mustard-based biofertility product TerraSante in Oregon is another positive driver for the company's revenue growth, analysts at Noble believe. In a note to clients, the analysts highlighted that the Oregon...
MustGrow to commence sales of TerraSante in Oregon
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has received The State of Oregon Agricultural Fertilizer Registration Certificate for its mustard plant-based TerraSante, allowing it to commence sales of the organic biofertility product in Oregon. The company noted that its...
Source: https://incomestatements.info
Category: Stock Reports